GlaxoSmithKline to pay $3bn in US drug fraud scandal
GlaxoSmithKline (GSK) is to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in US history.
The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).
The settlement will cover criminal fines as well as civil settlements with the federal and state governments.
Michelle Fleury reports.
Most watched/listened
-
'Massive tornado coming towards us'
-
'Complete devastation' after Tornado
-
Huge tornado hits Oklahoma City
-
'First crane egg in 400 years'
-
Teenager plans to go to Mars by 2030
-
Father faces child death charges
-
What do Venezuelans want in a president?
-
Creative brains map a smarter future
-
Super Rich: Private jet company soars
-
Tornadoes tear through US states
-
Private jets flying high in downturn
-
Toilet paper shortage in Venezuela
-
Whisky sales fuel copper stills boom
-
Justin Bieber defies his critics
-
'Absolute destruction' after tornado
~RS~q~RS~~RS~z~RS~13~RS~)
